Over the last 12 months, one Scientific Industries Inc executives and directors added shares on the open market, about $45,000 in total, and none of them sold.
Biggest single buyer: MOORE JOHN A, Chair, with roughly $12,000.
Looking at the quarterly pattern: 6 quarters in a row of net buying by insiders. Insiders bought in 6 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | MOORE JOHN A | Chair | Buy | 5,000 | $0.76 | $4K | SEC |
| Aug 20, 2026 | MOORE JOHN A | Chair | Buy | 14,700 | $0.71 | $10K | SEC |
| Jun 18, 2026 | MOORE JOHN A | Chair | Buy | 4,000 | $0.71 | $3K | SEC |
| Mar 24, 2026 | MOORE JOHN A | Chair | Buy | 9,000 | $0.58 | $5K | SEC |
| Mar 17, 2026 | MOORE JOHN A | Chair | Buy | 1,000 | $0.65 | $650 | SEC |
| Dec 18, 2025 | MOORE JOHN A | Chair | Buy | 6,500 | $0.53 | $3K | SEC |
| Dec 18, 2025 | MOORE JOHN A | Chair | Buy | 11,700 | $0.54 | $6K | SEC |
| Dec 15, 2025 | MOORE JOHN A | Chair | Buy | 20,000 | $0.60 | $12K | SEC |
| Sep 18, 2025 | MOORE JOHN A | Chair | Buy | 5,800 | $0.70 | $4K | SEC |
| Sep 18, 2025 | MOORE JOHN A | Director | Buy | 9,599 | $0.64 | $6K | SEC |
| May 19, 2025 | MOORE JOHN A | Chair | Buy | 35,000 | $1.00 | $35K | SEC |
| May 19, 2025 | BLECHMAN MICHAEL | Director | Buy | 10,000 | $1.00 | $10K | SEC |
| May 15, 2025 | NICOLS JOHN J | Director | Buy | 15,000 | $1.00 | $15K | SEC |
| Apr 22, 2025 | Bleichroeder LP | 10% Owner | Buy | 250,000 | $1.00 | $250K | SEC |
| Oct 31, 2024 | MOORE JOHN A | Chair | Buy | 7,000 | $0.97 | $7K | SEC |
In the last 12 months Scientific Industries Inc insiders made open-market purchases worth about $45,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in SCND was filed on 2026-09-08.
No congressional trades in SCND were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).